MorphoSys Shares Fall After Raising Funds to Accelerate Drug Launch, Trials
By Nina Kienle MorphoSys shares fell after the company raised 102.7 million euros ($111.7 million) in a capital increase to accelerate the launch of a...
Stay updated with breaking news from Service Testing. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
By Nina Kienle MorphoSys shares fell after the company raised 102.7 million euros ($111.7 million) in a capital increase to accelerate the launch of a...
Moderna's stock was on track for its biggest one-day gain in more than a year.
Vertex disclosed promising test results for a drug that could offer an alternative to opioids.
By Adria Calatayud Novartis's investigational drug iptacopan achieved its primary goal in a late-stage clinical trial for treatment of kidney disease C3...
By Sabela Ojea Shares of Anixa Biosciences climbed 14% to $4.47 in after-hours trading after the company presented positive results regarding its Phase 1...